A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

Autor: Patil VM; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Agarwal J; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India., Ghosh-Laskar S; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India., Budrukkar A; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India., Murthy V; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India., Gupta T; Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India., Mahimkar M; Mahimkar Laboratory, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India., Juvekar S; Department of Radiology, Tata Memorial Hospital, HBNI, Mumbai, India., Arya S; Department of Radiology, Tata Memorial Hospital, HBNI, Mumbai, India., Mahajan A; Department of Radiology, Tata Memorial Hospital, HBNI, Mumbai, India., Agarwal A; Department of Nuclear Medicine, Tata Memorial Hospital, HBNI, Mumbai, India., Purandare N; Department of Nuclear Medicine, Tata Memorial Hospital, HBNI, Mumbai, India., Rangarajan V; Department of Nuclear Medicine, Tata Memorial Hospital, HBNI, Mumbai, India., Balaji A; Department of Speech and Therapy, Tata Memorial Hospital, HBNI, Mumbai, India., Chaudhari SV; Biocon Ltd, Bengaluru, India., Banavali S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Kannan S; Department of Biostatistics, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India., Bhattacharjee A; Department of Epidemiology, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India., D'Cruz AK; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Chaturvedi P; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Pai PS; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Chaukar D; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Pantvaidya G; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Nair D; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Nair S; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Deshmukh A; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Thiagarajan S; Department of Head and Neck Surgery, Tata Memorial Hospital, HBNI, Mumbai, India., Mathrudev V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Manjrekar A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Dhumal S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Maske K; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Bhelekar AS; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Nawale K; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Chandrasekharan A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Pande N; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Goel A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Talreja V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Simha V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Srinivas S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Swami R; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Vallathol DH; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Dsouza H; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Shrirangwar S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Turkar S; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Abraham G; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Thanky AH; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Patel U; Mahimkar Laboratory, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India., Pandey MK; Mahimkar Laboratory, Advanced Center for Treatment, Research, and Education in Cancer, Navi Mumbai, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.

Publikováno v: Cancer [Cancer] 2019 Sep 15; Vol. 125 (18), pp. 3184-3197. Date of Electronic Publication: 2019 May 31.

Epidemiology and Outcomes with Platinum-Based Chemotherapy in Recurrent or Metastatic Carcinoma Cervix in a Developing Country: Experience from a Tertiary Oncology Centre in Southern India.

Autor: Lakshmaiah KC; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Thanky AH; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Lokanatha D; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Govind Babu K; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Jacob L; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Babu S; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Rudresha AH; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Lokesh KN; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Rajeev LK; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Sridharmurthy A; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.

Publikováno v: The Gulf journal of oncology [Gulf J Oncolog] 2017 Sep; Vol. 1 (25), pp. 20-26.

Can the Use of Bone Marrow Parameters Improve the Efficacy of Risk Prediction Scores in Chronic Myeloid Leukemia in Imatinib Era?

Autor: Kanakasetty GB; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Thanky AH; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India. Electronic address: aditik2008@yahoo.com., Kuntegowdanahalli L; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Dasappa L; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Jacob L; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Mallekavu SB; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Lakkavalli R; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Kadabur L; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Antapura R; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2017 Jun; Vol. 17 (6), pp. 375-381. Date of Electronic Publication: 2017 Mar 30.

Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India.

Autor: Kuntegowdanahalli LC; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Kanakasetty GB; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Thanky AH; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Dasappa L; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Jacob LA; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Mallekavu SB; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Lakkavalli RK; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Kadabur LN; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India., Haleshappa RA; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.

Publikováno v: Ecancermedicalscience [Ecancermedicalscience] 2016 Oct 06; Vol. 10, pp. 679. Date of Electronic Publication: 2016 Oct 06 (Print Publication: 2016).